Table 2.
In-vitro cytotoxicity of quinolines (9a-9e).
Compound | R 1 | R 2 | IC 50 (µM) | Survival a (%) (10µM ) | IC 50 (µM) | Survival b (%) (25µM) | ||
---|---|---|---|---|---|---|---|---|
MCF-7 | 48h 72h | T47D | 48h 72h | |||||
9d | cyclohexyl | <5 | 4 | 0.7 | 25 | 49.1 | 26.1 | |
9a | Ph | H | <10 | 38.3 | 26.7 | <25 | 33.8 | 25.4 |
9c | Phenyl | 10 | 48.4 | 41.3 | 50 | 75.8 | 68.9 | |
9b | Me | Me | 25 | 61 | 47.2 | 50 | 66.2 | 69.5 |
9e | H | H | >25 | 67.2 | 58.2 | 25 | 47.4 | 47.5 |
Doxorubicin | - | - | 0.25 | 50.2 | 31.7 | 0.1 | 53.2 | 27.1 |
Percent survival of MCF-7 cells following exposure to 10 µM concentration of compounds was determined after 48 h and 72 h exposure using MTT assay.
Percent survival of T47D cells following exposure to 25 µM concentration of compounds was determined after 48 h and 72h exposure using MTT assay.